The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey

M. Bocchetta, S. Galluzzi, P.G. Kehoe, E. Aguera, R. Bernabei, R. Bullock, M. Ceccaldi, J.F. Dartigues, A. de Mendonca, M. Didic, M. Eriksdotter, O. Felician, L. Frolich, H.J. Gertz, M. Hallikainen, S.G. Hasselbalch, L. Hausner, I. Heuser, F. Jessen, R.W. JonesA. Kurz, B. Lawlor, A. Lleo, P. Martinez-Lage, P. Mecocci, S. Mehrabian, A. Monsch, F. Nobili, A. Nordberg, M.O. Rikkert, J.M. Orgogozo, F. Pasquier, O. Peters, E. Salmon, C. Sanchez-Castellano, I. Santana, M. Sarazin, L. Traykov, M. Tsolaki, P.J. Visser, A.K. Wallin, G. Wilcock, D. Wilkinson, H Wolf, G. Yener, D. Zekry, G. B. Frisoni

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)195-206
JournalAlzheimers & Dementia
Volume11
Issue number2
DOIs
Publication statusPublished - 2015

Cite this

Bocchetta, M., Galluzzi, S., Kehoe, P. G., Aguera, E., Bernabei, R., Bullock, R., ... Frisoni, G. B. (2015). The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey. Alzheimers & Dementia, 11(2), 195-206. https://doi.org/10.1016/j.jalz.2014.06.006